The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
Juno Roche – writer, campaigner and woman living with HIV – shares her experiences on risk, HIV and being trans for International Transgender Day of Visibility (31 March).
PrEP, undetectable, on treatment … what does it all mean? Here we give you a quick run through in our jargon-busting blog.
New research marks welcome step to make trans women in sub-Saharan Africa visible in HIV data.
Language matters. Changing how people who use drugs are treated requires changing how we speak about them.
A US trial among 15 to 17 year-old men who have sex with men (MSM) suggests this group stands to benefit hugely should pre-exposure prophylaxis (PrEP) be approved – and supported – for this age group.
A ground-breaking review provides stark evidence of the damage criminalisation has on preventing and treating HIV among people who inject drugs.
A study of gay men in Malawi reveals very low levels of HIV testing and treatment access nationwide – with distinct geographic disparities in HIV prevalence that need to be taken into consideration and addressed.
The UNODC highlights disease burden, increased opioid abuse and a lack of treatment access in their global state of drug use report.
Disturbing patterns of mistreatment, discrimination, violence and harassment, with knock-on impacts on health and HIV risk, have been revealed by the largest ever survey of transgender people living in the United States of America (USA).
Reducing the number of age-disparate relationships in east and southern Africa could help to decrease HIV infection rates among young women in the region.